← Open Payments lookup

SHAUNTEL MARCIN: Open Payments

NPI 1689305948 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$713 in 41 payments from 13 companies in 2025. Trend: 2023 $751 · 2024 $734 · 2025 $713

Food & beverage: $713
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$136
Lundbeck LLC4$83
Neurocrine BioSciences, Inc.3$67
Takeda Pharmaceuticals U.S.A., Inc.4$64
Teva Pharmaceuticals USA, Inc.2$57
Alkermes, Inc.3$57
Vanda Pharmaceuticals Inc.4$56
ABBVIE INC.3$50
Otsuka America Pharmaceutical, Inc.3$47
E.R. Squibb & Sons, L.L.C.2$38

Products named: CAPLYTA, INGREZZA, TRINTELLIX, AUSTEDO XR, FANAPT, REXULTI, VRAYLAR, ABILIFY ASIMTUFII.

Industry payments across IN — which companies pay providers there.